The IMA Group Continues to Expand Evaluation Services Senior Leadership Team

Move highlights division’s growth; brings on noted industry experts Matt High and Elijah Marentette

TARRYTOWN, NY / ACCESSWIRE / June 25, 2024 / The IMA Group (IMA), a leading national provider of outsourced healthcare evaluation and clinical research site services, welcomes two experienced industry executives to its expanding Evaluation Services leadership team. Matt High will serve in a newly created position as Executive Vice President of Evaluation Services Operations, and Elijah Marentette will join as Vice President of Payer Services.

High, a seasoned healthcare and workers’ compensation executive, brings over two decades of industry expertise. His most recent role was as Senior Vice President of Operations at One Call. He has also held leadership positions within the Aetna/Coventry Workers’ Compensation organization.

In his new role as Executive Vice President of Evaluation Services Operations, High will be responsible for overseeing IMA’s Government Services and Occupational Health, Workers’ Compensation and Employer Solutions divisions. IMA Evaluation Services provides a wide range of medical, psychological, and ancillary evaluation services for government agencies and the workers’ compensation industries, including liability and disability independent medical exams (IME), case management services, fitness for duty/pre-employment evaluations, medical/psychological/ancillary exams, and a variety of occupational health services.

Marentette joins The IMA Group as Vice President of Payer Services, directly overseeing the company’s national IME platform and rapidly growing case management team. He will have strategic responsibility for innovating and continuously improving end-to-end operations, employee engagement, and customer experiences within the Payer division.

Before joining the IMA team, Elijah was the COO of Impact Health, a multi-state medical practice. He has also held senior executive positions leading products and divisions at Coventry, myMatrixx, and Concentra.

“As our Evaluation Services team grows, we recognize the need to expand our executive team to meet the evolving demands of healthcare,” said Mark Weinberger, Ph.D., MPH, President and CEO of IMA. “I look forward to working with Matt and Elijah to leverage our leadership, capitalize on synergies, and drive growth. Having worked together before, they will hit the ground running and be terrific additions to our team.”

Contact Information
Brenna Harrington
Account Manager, Scott Public Relations
brenna@scottpublicrelations.com
706-217-7809

Related Images

Elijah Marentette, The IMA Group
Elijah Marentette has been named Vice President of Payer Services for The IMA Group.
Matt High, The IMA Group
Matt High has been named Executive Vice President of Evaluation Services Operations for The IMA Group.

SOURCE: The IMA Group

View the original press release on newswire.com.

View the original press release on accesswire.com

Staff

Recent Posts

CelLBxHealth PLC Announces Board Changes

GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…

3 hours ago

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

4 hours ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

18 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

21 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

21 hours ago